Anavex Life Sciences’ (AVXL) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Wednesday morning,Benzinga reports. D. Boral Capital currently has a ...
Equities Analysts Issue Forecasts for VYGR FY2025 Earnings
Analysts at Wedbush decreased their FY2025 EPS estimates for Voyager Therapeutics in a research note issued on Tuesday, ...
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Given Consensus Rating of “Buy” by Brokerages
Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have received a consensus recommendation of “Buy” ...